This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Clifford John Harris
Introduction
Clifford John Harris is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazolo[1,5-a]pyrimidine derivatives. His research focuses on developing compounds that exhibit excellent MAPKAP-K2 inhibiting activity, which has potential therapeutic applications.
Latest Patents
Harris holds a patent for pyrazolo[1,5-a]pyrimidine derivatives. These compounds, represented by formula I, and their pharmaceutically acceptable salts are expected to be useful as therapeutic or prophylactic agents for disorders mediated by MAPKAP-K2. This includes inflammatory diseases, autoimmune diseases, destructive bone disorders, cancer, and tumor growth.
Career Highlights
Clifford John Harris is associated with Teijin Pharma Limited, where he continues to advance his research and development efforts. His work has the potential to impact various medical fields significantly.
Collaborations
Harris collaborates with esteemed colleagues such as Tomomi Kosugi and Minoru Imai, contributing to a dynamic research environment that fosters innovation.
Conclusion
Clifford John Harris is a prominent figure in the pharmaceutical industry, with a focus on developing innovative compounds that address critical health issues. His contributions through patents and collaborations highlight the importance of research in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile